Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease by Castaneda, Anu E. et al.
BRIEF ARTICLE
Cognitive functioning and depressive symptoms in 
adolescents with inflammatory bowel disease
Anu E Castaneda, Annamari Tuulio-Henriksson, Eeva T Aronen, Mauri Marttunen, Kaija-Leena Kolho
World J Gastroenterol  2013 March 14; 19(10): 1611-1617
ISSN 1007-9327 (print)  ISSN 2219-2840 (online)
© 2013 Baishideng. All rights reserved.
Online Submissions: http://www.wjgnet.com/esps/
wjg@wjgnet.com
doi:10.3748/wjg.v19.i10.1611
1611 March 14, 2013|Volume 19|Issue 10|WJG|www.wjgnet.com
Anu E Castaneda, Department of Mental Health and Substance 
Abuse Services, National Institute for Health and Welfare, 00271 
Helsinki, Finland
Annamari Tuulio-Henriksson, Research Department, Social 
Insurance Institute, 00250 Helsinki, Finland
Eeva T Aronen, Child Psychiatry, Children’s Hospital, Univer-
sity of Helsinki and Helsinki University Central Hospital, 00250 
Helsinki, Finland
Mauri Marttunen, Department of Adolescent Psychiatry, Uni-
versity of Helsinki and Helsinki University Central Hospital, 
00271 Helsinki, Finland
Mauri Marttunen, Department of Mental Health and Substance 
Use Services, National Institute for Health and Welfare, 00271 
Helsinki, Finland
Kaija-Leena Kolho, Hospital for Children and Adolescents, De-
partment of Pediatric Gastroenterology, University of Helsinki, 
00250 Helsinki, Finland
Author contributions: Castaneda AE performed the statisti-
cal analyses and wrote the first draft and the final version of the 
manuscript; Tuulio-Henriksson A contributed methodological 
and neuropsychological expertise; Aronen ET and Marttunen 
M contributed psychiatric expertise on studies in adolescents; 
Kolho KL brought the original idea of the study, contributed 
expertise on adolescent inflammatory bowel disease and was in 
charge of the clinical evaluation of the patients; all authors con-
tributed to designing the study protocol and manuscript writing 
and approved the final version of the manuscript.
Supported by Foundation of Päivikki and Sakari Sohlberg, the 
Emil Aaltonen Foundation, the Foundation for Pediatric Re-
search, the Helsinki University Central Hospital Research Fund, 
and the Academy of Finland
Correspondence to: Anu E Castaneda, PhD, Department of 
Mental Health and Substance Abuse Services, National Institute 
for Health and Welfare, Mannerheimintie 166, Helsinki PO Box 
30, 00271 Helsinki, Finland. anu.castaneda@thl.fi
Telephone: +358-29-5248597  Fax: +358-29-5248478
Received: October 15, 2012      Revised: December 12, 2012 
Accepted: December 15, 2012
Published online: March 14, 2013
Abstract
AIM: To investigate cognitive functioning and depres-
sive symptoms in adolescents with inflammatory bowel 
disease (IBD).
METHODS: A neuropsychological test battery, includ-
ing subtests of the Wechsler Adult Intelligence Scale-
Revised and Ⅲ, Wechsler Memory Scale-Revised, Cali-
fornia Verbal Learning Test (CVLT), Stroop Color-Word 
Test, and Trail Making Test, which assessed verbal 
and visual short- and long-term memory, processing 
speed, logical reasoning, verbal intelligence, attention, 
and executive functioning, was administered to 13- to 
19-year-old patients with IBD (n  = 34; active disease n  
= 20). Depressive symptoms were measured with the 
Beck Depression Inventory. The findings were com-
pared with peers with non-acute juvenile idiopathic 
arthritis (JIA; n  = 23). Patients with coexisting psychi-
atric disorders were excluded.
RESULTS: The IBD group, especially patients in the 
acute phase, made more perseverative errors in the 
CVLT test that assessed verbal memory than the JIA 
group (6.0 ± 4.3 vs  3.3 ± 2.9, P  < 0.01), but no other 
differences between the IBD and JIA groups were ob-
served in the neuropsychological tests. The difference 
was close to statistical significance, even when gluco-
corticoid medication was controlled for (P  < 0.052). 
The IBD group had more depressive symptoms than 
the JIA group (7.9 ± 7.6 vs  4.0 ± 4.0, P  < 0.05). Ap-
proximately one third of the IBD group had at least 
mild depressive symptoms, and those with acute illness 
had the highest scores. However, depressive symptoms 
were not related to the difference in the verbal memo-
ry test (perseverative errors in the CVLT) between the 
IBD and JIA groups.
CONCLUSION: Adolescents with acute IBD may have 
mild verbal memory problems but no major cognitive 
deficits compared to peers with JIA.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic life-long 
disease comprising Crohn’s disease, ulcerative colitis and 
unclassified colitis that may appear at any age. The inci-
dence of  IBD among adolescents is increasing[1-3], and 
thus, it is important to study the possible burden of  the 
disease on the everyday life of  the patients. According 
to parent reports, adolescents with IBD have more emo-
tional, social, and thought problems and lower compe-
tence than their healthy peers[4]. The disease affects the 
quality of  life of  adolescents[5-7], may have negative con-
sequences on education and school functioning[8,9], and 
may cause higher unemployment later in life[10-13]. Fur-
thermore, adolescents with severe IBD have disturbed 
sleep and are overtired more often than their healthy 
peers[14]. However, research on cognitive dysfunction, 
which refers to deficits in cognitive information process-
ing, is scarce in patients suffering from IBD.
Two prior studies[15,16] on adults found some cogni-
tive difficulties among patients with IBD. Attree and co-
authors[15] reported poorer performance in a test mea-
suring verbal functioning in adults with IBD compared 
to healthy controls. There were, however, no differences 
in tests assessing attention and mental speed. The other 
study[16] also showed that adults with IBD had a decrease 
in verbal functioning compared with healthy controls 
and that this was unlikely to be due to premorbid levels 
of  intellectual functioning. Thus, like many other chronic 
illnesses, IBD seems to be accompanied by some cogni-
tive deficits among adults. However, there are no stud-
ies on cognitive functioning among adolescent patients 
with IBD. In addition, it is not known whether the phase 
of  the illness is associated with cognitive functioning. 
Given that this disorder often begins in adolescence, it is 
important to examine whether the illness has an impact 
on cognitive development and, consequently, the perfor-
mance of  young patients at school.
Depressive symptoms are common among adults[17] 
and adolescents with IBD[18-20]. Depression may also be 
associated with cognitive impairments[21,22]. In particular, 
early-onset depression may be related to deficits in at-
tention, memory, and executive functioning[23,24]. Depres-
sive symptoms in adolescence might be associated with 
serious and long-lasting psychosocial difficulties, such 
as problems in education and work[25], and cognitive im-
pairments in adolescence and early adulthood may also 
complicate school performance and affect successful psy-
chosocial development. Therefore, adolescence is a key 
period for both the recognition and treatment of  mental 
health and cognitive problems associated with somatic 
illnesses to avoid long-term sequelae in several areas of  
psychosocial functioning. Taken together, more studies 
are needed on illness-related psychosocial and cognitive 
correlates to improve the care and assessment of  young 
IBD patients.
The main aim of  the present study was to examine 
cognitive functioning among adolescent patients with 
IBD and investigate whether disease activity or depres-
sive symptoms were associated with cognitive function-
ing. As a clinical comparison group, an adolescent pa-
tient group with minor symptoms of  a chronic disease, 
juvenile idiopathic arthritis (JIA) in the non-acute phase, 
was included. It was hypothesized that IBD would be 
related to difficulties in cognitive functioning, especially 
in verbal functions and that these difficulties would be 
more pronounced in the acute phase of  the disorder.
MATERIALS AND METHODS
Participants
The study groups were enrolled during May 2008-March 
2009 at the Hospital for Children and Adolescents, Hel-
sinki, Finland. Consecutive IBD patients aged 13 years 
or older were invited to participate in the study along 
with their routine outpatient visits. Likewise, consecutive 
non-acute JIA patients of  the same age group, followed-
up at the same outpatient facilities, were invited to par-
ticipate to represent a control group with non-acute 
chronic illness (identical recruitment procedure). Patients 
with coexisting psychiatric, neurological, or develop-
mental disorders (based on hospital case records and 
information from the patients and their parents) were 
excluded. All patients were native Finnish speakers and 
attended regular school, and none had particularly poor 
school performance (based on self-reports). There were 
17 decliners (IBD n = 8, JIA n = 9). The decliners did 
not differ from those who participated in age, gender, 
or severity of  the disorder, and the reason for refusal 
was mainly lack of  time. One participant underwent the 
procedure but was excluded later because of  previously 
diagnosed neuropsychological difficulties and special 
education at school. None of  the included patients had 
major learning disabilities, but one patient with IBD 
self-reported as being diagnosed with minor dyslexia 
in secondary school, with the problems overcome. The 
final study sample consisted of  34 IBD patients aged 13 
to 19 years (ulcerative colitis n = 16, Crohn’s disease n 
= 17, and unclassified colitis n = 1) and 23 JIA patients 
aged 14-19 years (Table 1). Most patients were full-time 
students, and only two persons were employees. Current 
medication included 5-aminosalicylic acid (n = 26), aza-
thioprine (n = 11), glucocorticoids (n = 17), and antibiot-
ics (n = 3) in the IBD group and methotrexate (n = 11), 
anti- tumor necrosis factor-α agent (n = 4), chloroquine (n 
Table 1  Background data of the study groups
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= 1), leflunomide (n = 1), and sulfasalazine (n = 1) in the 
JIA group. Three patients with Crohn’s disease had un-
dergone surgery more than six months prior to the neu-
ropsychological examination. None of  the patients had 
current psychotropic medication or ongoing psychiatric 
treatments. The study was approved by the Ethics Com-
mittee of  the Hospital District of  Helsinki and Uusimaa, 
and it conformed to the provisions of  the Declaration 
of  Helsinki and its amendments. Written informed con-
sent was obtained after a complete description of  the 
study from each examined patient or a parent when the 
examinee was under 18 years of  age.
Socioeconomic status
The socioeconomic status of  the adolescent’s family was 
classified according to Helsinki City socioeconomic sta-
tistics: class Ⅰ included persons with an academic degree, 
business managers, and professionals (e.g., engineers); class 
Ⅱ included administrative personnel, owners of  small 
businesses, and minor professionals (e.g., graduate nurse); 
class Ⅲ included skilled manual employees (e.g., laboratory 
assistant); and class Ⅳ included unskilled employees (e.g., 
domestic maid). This grading is adapted nationally and 
comparable to international classification[26]. The higher 
socioeconomic class of  the parents was considered to be 
the socioeconomic class of  the family (Table 1).
Clinical evaluation
The activity of  IBD was based on the clinical evaluation 
of  experienced clinicians (Physician’s Global Assessment) 
and inflammatory markers [erythrocyte sedimentation 
rate (ESR), C-reactive protein, and fecal calprotectin, with 
values < 100 μg/g of  stool considered normal and values 
>1000 μg/g considered exceedingly high][27]. The disease 
activity in JIA was based on the child health assessment 
questionnaire and clinical evaluation by a pediatric rheu-
matologist.
On the day of  the neuropsychological assessment, 
patients also completed a questionnaire in the Finnish 
language gathering information on depressive symptoms 
and background factors. Depressive symptoms were mea-
sured with the Beck Depression Inventory (BDI)[28]. The 
BDI is a 21-item questionnaire in which the items are 
answered using a 4-point rating scale ranging from 0 to 3. 
High scores indicate a high level of  depressive symptoms. 
The total score was calculated and used in the statistical 
analyses. Additionally, the BDI total score was catego-
rized into four classes by classifying scores from 0 to 9 
as no symptoms, 10 to 18 as mild symptoms, 19 to 29 as 
moderate symptoms, and 30 to 63 as severe symptoms. 
Five patients had one missing value in the BDI, which 
was replaced by their individual item mean scores of  the 
BDI. The patients also completed an in-house question-
naire with questions on school performance, subjective 
view of  learning difficulties, sick leave, employment, and 
parental professions.
Neuropsychological examination
The neuropsychological examination was conducted 
individually by a psychologist blinded to the presence 
of  diagnosis or disease activity prior to the examination. 
The examination took place in one session of  approxi-
mately one hour. The neuropsychological test battery, 
including Finnish versions of  internationally used, vali-
dated test methods administered in a fixed order, was 
selected to allow for the comparison of  verbal and vi-
sual short-term memory, verbal long-term memory and 
learning, attention, logical reasoning and social insight, 
psychomotor processing speed, and executive function-
ing between the study samples. Because the cognitive 
functioning of  adolescents with IBD has not been pre-
viously investigated, the tests were chosen to evaluate a 
wide range of  neuropsychological functions instead of  
focusing on only some specific functions. Tests were 
scored according to standardized procedures by the ex-
aminer.
Auditory attention and verbal working memory were 
assessed with the Digit Span Forward and Backward 
subtests, respectively, of  the Wechsler Memory Scale, Re-
vised[29] (WMS-R). Visual attention and working memory 
were measured with the Visual Span Forward and Back-
ward subtests, respectively, of  the WMS-R[29]. Visuo-mo-
tor performance and processing speed were assessed with 
the Digit Symbol subtest of  the Wechsler Adult Intel-
ligence Scale, Revised[30] (WAIS-R). General verbal intel-
ligence was estimated with the Vocabulary subtest of  the 
WAIS-R[30], and logical reasoning and social insight were 
assessed with the Picture Arrangement subtest of  the 
WAIS-Ⅲ[31]. The Stroop Color-Word Test[32] (Golden), 
given in three parts, was administered to evaluate execu-
tive functioning, and the interference score was calcu-
lated and used in the analysis. The Trail Making Test[33] 
(TMT), given in two parts, was administered to evaluate 
attentive and executive functioning. Part A measures 
visuo-spatial attention and performance speed, whereas 
Part B requires mental flexibility, ability to shift attention, 
IBD (n  = 34) JIA (n  = 23)
Age (yr) 16.3 ± 1.7 13.6-19.7 15.5 ± 1.2 14.0-18.6
Age at receiving the 
diagnosis (yr)
12.7 ± 3.5  2.0-16.7   9.0 ± 4.6   1.3-15.0
Gender (female) 15 (44) 14 (61)
Socioeconomic status1
   Class Ⅰ 10 (32) 11 (50)
   Class Ⅱ   9 (29)   3 (14)
   Class Ⅲ 12 (39)   7 (32)
   Class Ⅳ 0 (0) 1 (5)
State (acute) 20 (59) 0 (0)
Disease duration
   Less than one year   6 (18) 2 (9)
   One to two years 10 (29) 1 (4)
   More than two years 18 (53) 20 (87)
1Data missing for three inflammatory bowel disease (IBD) and one juvenile 
idiopathic arthritis (JIA) patients. Data are expressed as absolute n (%) or 
mean ± SD.
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and strategy. Possible errors made by the examinee were 
not corrected by the examiner. The time to complete 
Parts A and B and the difference in score between B and 
A (the executive aspect of  the task when the speed com-
ponent is removed) were used in the statistical analysis. 
The California Verbal Learning Test[34] (CVLT), in which 
the examinee is required to learn a 16-item word list over 
five trials and recall and/or recognize it after short and 
long delays, was used to measure various aspects of  ver-
bal learning and memory. The following variables of  the 
CVLT were included in the statistical analyses: Total Re-
call from trials 1-5 (learning performance), Short-Delay 
Free Recall (short delay memory performance), Long-
Delay Free Recall (long delay memory performance), 
Discriminability (recognition memory taking into ac-
count both hits and false positives), Perseverative Repeti-
tion Errors, Intrusion Errors, Semantic Clustering (the 
use of  an active learning strategy of  reorganizing target 
words into categorical groups), and Learning Slope (the 
increase in recalled words per trial over trials 1-5). High-
er scores indicate better performance in all tests, except 
in the Stroop test, TMT and Perseverative and Intrusive 
Errors of  the CVLT.
Three IBD patients had missing values in neuropsy-
chological tests: the Stroop test performance of  two 
patients was excluded due to red-green color blindness. 
One patient had distractions during the testing situation, 
and therefore, the results of  the Picture Arrangement 
and the Stroop test were considered invalid in this case.
Statistical analysis
Pearson’s χ 2 test was used to compare differences in gen-
der, a one-way analysis of  variance (ANOVA) was used 
to compare differences in age, and a two-tailed Mann-
Whitney test was used to compare differences in the 
socioeconomic status of  the adolescent’s family between 
the study groups.
Neuropsychological test scores were compared be-
tween the IBD and JIA groups with a univariate ANO-
VA. The main group comparisons were performed sepa-
rately for each test score as a dependent variable, with 
group membership as an independent variable and gen-
der as an additional independent variable to adjust for 
gender effects. Neuropsychological test performance was 
also compared between subgroups of  active and non-
active IBD groups and the JIA group with Bonferroni’s 
post hoc test. To adjust for the effects of  glucocorticoids, 
group comparisons of  neuropsychological functioning 
were conducted when this medication (yes vs no) was 
treated as an additional independent variable.
Depressive symptoms were compared between the 
groups with ANOVA. ANOVAs with post hoc tests, cor-
rected for multiple testing with the Bonferroni correc-
tion, were also used to compare depressive symptoms 
between the subgroups of  active and non-active IBD pa-
tients and the JIA group. Linear regression models were 
used to predict depression score by age or gender. In ad-
dition, to adjust for the effects of  depressive symptoms 
on neuropsychological test performance, these group 
comparisons were also conducted with the continuous 
BDI score as an additional covariate factor.
All analyses were conducted with SPSS 16.0 software, 
and a P value < 0.05 was defined as indicating a statisti-
cally significant result throughout the study. Raw test 
scores were used. Scores that were not normally distribut-
ed were log (TMT: A, B, B-A; CVLT: Perseverations, In-
trusions) or cube (CVLT: Discriminability) transformed.
RESULTS
The IBD and JIA groups did not differ in age (F = 3.210, 
υ  = 1, 55, P = 0.079), gender (χ 2 = 1.540, υ  = 1, P = 0.215), 
or socioeconomic status of  the family (U = 304.500, P 
= 0.483). Among IBD patients with the acute state (n = 
20), the median ESR was 19 mm/h (range from 3 to 53 
mm/h), fecal calprotecin was 870 μg/g (range from 101 
to 3130 μg/g), and 14 of  the 20 patients were on gluco-
corticoids. The respective figures for IBD patients with 
quiescent disease (n = 14) were 4 mm/h for ESR (from 1 
to 28 mm/h), 183 μg/g for fecal calprotectin (from 150 
to 505 μg/g) and three on low-dose glucocorticoids.
The only statistically significant difference in the neu-
ropsychological test performance between the groups 
appeared in Perseverative Repetition Errors of  the CVLT, 
with the IBD group performing poorer than the JIA 
group (Table 2). When the subgroups of  active and non-
active IBD patients were compared with each other and 
the JIA group, the only difference was again in Persever-
ation Errors (F = 5.150, υ  = 2, 51, P = 0.009), with the 
acute IBD group performing poorer than the JIA group 
(P = 0.027; other data not shown). When glucocorticoid 
medication was treated as an additional independent 
variable, the difference in Perseveration Errors was close 
to the level of  statistical significance (F = 3.948, υ  = 1, 
51, P = 0.052; other data not shown).
The IBD group had scores suggesting more depres-
sive symptoms than the JIA group (mean ± SD, IBD: 7.9 
± 7.6, JIA: 4.0 ± 4.0; F = 5.046, υ  = 1, 55, P = 0.029), 
especially IBD patients in the active disease phase (F = 
3.966, υ  = 2, 54, P = 0.025; active IBD vs JIA P = 0.022). 
In the IBD group, 24% had scores suggesting mild de-
pressive symptoms (half  of  the patients were in the ac-
tive and half  in the non-active state), and 9% had scores 
suggesting moderate or severe depressive symptoms (all 
in the active state). In the JIA group, 9% had scores for 
mild depressive symptoms, while none had moderate or 
severe symptoms. None of  the patients reported suicidal 
ideation or suicidal behavior in the BDI. The depression 
score was not predicted by age (β  = 0.247, υ  = 1, 55, P 
= 0.064) or gender (F = 2.766, υ  = 1, 55, P = 0.102).
When the BDI score was set as a covariate in the 
group comparisons of  the neuropsychological data, the 
difference in Perseveration Errors remained significant 
between the study groups (F = 4.591, υ  = 1, 52, P = 
0.004), and no other differences between the groups 
emerged (data not shown).
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DISCUSSION
To our knowledge, this is the first study that describes 
cognitive functioning in adolescent patients with IBD. 
We found only minor impairments in the verbal memory 
test, in which IBD patients, particularly in the acute 
phase, produced more perseverative errors than patients 
with non-acute JIA. Perseveration in the CVLT test may 
be related to a momentary loss of  alertness in the tire-
some and long verbal memory test. However, no other 
differences in cognitive functioning between the study 
groups were detected. These findings indicate that ado-
lescents with active IBD may have some mild problems 
in verbal memory but no major cognitive deficits. The 
two prior studies in adults with IBD found deficits, par-
ticularly in verbal functioning[15,16], suggesting that in the 
clinical evaluation of  young patients with IBD, it may be 
relevant to pay attention to even minor cognitive prob-
lems that may be aggravated in the process of  growing 
up.
Depressive symptoms were measured using the BDI 
on the same day as the neuropsychological examina-
tion. Adolescents with IBD, especially those in the acute 
phase of  the illness, may more commonly have depres-
sive symptoms compared with peers with mild disease 
or non-acute JIA. Approximately one third of  the IBD 
patients had scores indicative of  at least mild depres-
sive symptoms, and some of  those with acute illness 
scored for moderate or severe symptoms. This finding 
is noteworthy, as in non-acute JIA, no patients reported 
moderate or severe depressive symptoms, and less than 
one out of  ten reported mild symptoms. In line with our 
results, previous studies have described depressive symp-
toms among young patients with IBD[18-20]. Although 
the minor impairment in the verbal memory test in IBD 
patients was not explained by the severity of  depressive 
symptoms, depressed mood may have other severe and 
long-lasting consequences for the psychosocial function-
ing of  these patients.
One limitation of  the present study is the lack of  
a healthy control group, which potentially weakens 
the generalization of  the findings. The patient control 
group was chosen to represent adolescents with similar 
life surroundings (chronic disorder with inflammatory 
pathology) but with less severe health problems that 
have not been found to be related to cognitive defi-
cits[35]. The strength of  the present study is that the JIA 
patients underwent exactly the same procedure as the 
IBD group in the outpatient clinic of  the same hospital 
during the same time period and with the same examin-
ers, who were blinded to patient data. Furthermore, the 
patient groups did not differ in age or gender. There 
was no major attrition of  participants that could limit 
the interpretation of  the results; however, the sample 
IBD (n  = 34) JIA (n  = 23) IBD vs  JIA
F 1 υ P  value
Attention
   WMS-R: Digit span forward   7.3 ± 1.4   7.0 ± 1.8 0.866 1, 53 0.356
   WMS-R: Visual span forward   8.3 ± 1.6   8.5 ± 2.0 0.054 1, 53 0.817
   TMT: A (time) 31.2 ± 8.6 31.0 ± 8.6 0.000 1, 53 0.989
Executive functioning
   TMT: B (time)   74.7 ± 25.3   66.4 ± 15.0 0.812 1, 53 0.372
   TMT: B-A (time)   43.6 ± 22.1   35.3 ± 14.0 0.986 1, 53 0.325
   Stroop: Interference score (time)   56.5 ± 13.9   57.9 ± 19.5 0.190 1, 50 0.665
Working memory
   WMS-R: Digit span backward   6.3 ± 1.7   6.1 ± 1.5 0.596 1, 53 0.444
   WMS-R: Visual span backward   8.7 ± 1.3   8.3 ± 1.3 1.218 1, 53 0.275
Processing speed
   WAIS-R: Digit symbol   55.3 ± 10.0 56.7 ± 9.7 0.001 1, 53 0.970
Basic ability
   WAIS-R: Vocabulary 39.7 ± 9.7   40.6 ± 10.4  0.0492 1, 53 0.826
Logical reasoning/social insight
   WAIS-Ⅲ: Picture arrangement 13.4 ± 4.0 12.9 ± 4.2 0.277 1, 52 0.601
Verbal learning and memory
   CVLT: Total recall of trials 1-5 55.3 ± 8.7 56.8 ± 8.3 0.009 1, 53 0.925
   CVLT: Short-delay free recall 11.7 ± 2.9 11.4 ± 3.1  0.2502 1, 53 0.619
   CVLT: Long-delay free recall 12.3 ± 2.5 12.5 ± 2.3 0.010 1, 53 0.920
   CVLT: Discriminability   1.0 ± 0.0   1.0 ± 0.0 0.280 1, 53 0.599
   CVLT: Perseverative errors   6.0 ± 4.3   3.3 ± 2.9 8.249 1, 53 0.006
   CVLT: Intrusion errors   2.8 ± 3.4   2.0 ± 2.8 0.527 1, 53 0.471
   CVLT: Semantic clustering   1.8 ± 0.7   1.7 ± 0.7 0.168 1, 53 0.683
   CVLT: Learning slope   1.3 ± 0.3   1.2 ± 0.5  0.3462 1, 53 0.559
1A one-way analysis of variance (group and gender as independent factors); 2Levene’s test of equality of error variances P < 0.05. 
IBD: Inflammatory bowel disease; JIA: Juvenile idiopathic arthritis; WMS-R: Wechsler Memory Scale-Revised; WAIS-Ⅲ: Wechsler 
Adult Intelligence Scale-Third Edition; WAIS-R: Wechsler Adult Intelligence Scale-Revised; TMT: Trail Making Test; CVLT: Califor-
nia Verbal Learning Test.
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sizes were still relatively small. Another limitation is that 
there may be some potential confounders, such as sleep 
disturbances or acute stressful life events, e.g., divorce of  
parents, that should be taken into account. In the IBD 
group, the majority (70%) of  the patients in the acute 
state were on glucocorticoids, which may affect cogni-
tive functioning[36]. Unfortunately, the total exposure 
time of  glucocorticoids was not available. However, it 
is unlikely that the only reason for the minor problem 
in the verbal memory test was glucocorticoids because 
the group difference between the IBD and JIA patients 
remained close to the level of  statistical significance 
when glucocorticoid medication was adjusted for in the 
statistical analyses. Furthermore, in active IBD, patients 
need either glucocorticoids or other immunosuppressive 
therapy, and it would be unethical to decline these medi-
cations for study purposes. Thus, studying treatment-
naïve patients with active IBD is challenging.
Taken together, this is the first study that investigates 
cognitive functioning in adolescents with IBD. The re-
sults indicate that young patients with IBD, especially in 
the acute state of  the disease, may have some problems 
in verbal memory, particularly when assessed with a test 
requiring alertness in a tiresome context. However, no 
major cognitive deficits among young patients with IBD 
were found compared to peers with JIA. The clinical 
significance of  this finding and its possible impact on 
school performance, is unclear, warranting further stud-
ies. Likewise, the relation of  cognitive functioning to 
medication and disease-related factors, such as sleep dis-
turbances or depression, needs to be assessed in larger 
study samples. In particular, longitudinal studies on 
disease activity and cognitive functioning related to psy-
chosocial functioning are warranted in adolescents with 
IBD.
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